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1. Introduction

L

eft ventricular assist devices (LVAD) are
currently utilized as both bridge and destination therapy for patients with end-stage heart
failure. Current generation LVADs provide
continuous blood ﬂow which has been shown to
increase sympathetic tone. Pheochromocytoma is
a rare neuroendocrine tumor which classically
presents with episodic hypertension, palpitations
and headaches. Careful perioperative management with alpha blockade is required to prevent
cardiovascular complications, speciﬁcally hypertensive crisis. Here we present a description of
perioperative management of pheochromocytoma in a patient with a continuous ﬂow LVAD.

2. Case Report
A 70 year old male with a history of mixed
ischemic and non-ischemic cardiomyopathy, hypertension, hyperlipidemia, atrial ﬁbrillation, coronary artery disease requiring percutaneous
coronary intervention, obesity, and obstructive sleep
apnea presented with refractory ventricular tachycardia. Despite aggressive attempts at medical
management and ablation, his VT could not be
controlled and durable left ventricular assist device
(HeartMate III VAD, Abbott) was implanted. During

his advanced therapies evaluation, elevated levels of
metanephrine were identiﬁed. Subsequent imaging
diagnosed pheochromocytoma (see Fig. 1) and surgical resection was planned.
Seven days prior to scheduled surgical resection,
the patient was admitted to the intensive care unit
for alpha blockade and heparin bridging. Guideline
recommendations for pheochromocytoma management include volume expansion, high sodium diet
and alpha adrenergic receptor blockade. Given the
patient's history of advanced heart failure, diuretics
were held but he has not supplied a high sodium
diet or given intravenous ﬂuid. The patient was
continued on carvedilol 3.125 mg twice daily. Phenoxybenzamine was initiated at 10 mg twice daily
with daily monitoring of orthostatic vitals. While the
patient remained asymptomatic throughout, a
measurable drop in mean arterial pressure from his
baseline 80 mmHg to 60e65 mmHg was noted after
phenoxybenzamine reached 40 mg orally twice a
day. He also exhibited episodes of asymptomatic
orthostatic hypotension.
Perioperative orthostasis is the normal goal of
uptitration of alpha blockade however this proved
difﬁcult. The LVAD likely compensated for the hemodynamic changes thereby preventing orthostasis.
Induction of anesthesia was attained utilizing propofol and sufentanil in titrated doses and maintained with narcotics and inhaled sevoﬂurane.
Desﬂurane was avoided speciﬁcally due to its sympathomimetic side effects. Muscle relaxation was
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Fig. 1. (A) Abdominal CT imaging demonstrating right adrenal tumor (red arrow). (B) Metaiodobenzylguanidine (MIBG) scan showing increased
activity of right adrenal gland raising suspicion of pheochromocytoma (red arrow).

attained with cisatracurium. Mean pressures during
the procedure were kept within 20% of starting
mean pressures with maintenance of anesthesia.
Further vasodilators were not required although the
mean pressures were in the 90 range. More
aggressive hypertensive management was avoided
to ensure cerebral perfusion during the case and
cerebral oximetry was used to monitor cerebral
perfusion. Two separate times during dissection
systolic blood pressures spiked to greater than
220 mm Hg and were treated with pausing of
dissection of small doses of IV phentolamine
(0.1 mg). LVAD ﬂows dropped from 5.2 lpm with a
PI of 2.0e4.8 lpm with a PI of 2.4 during these
events. Once resection had taken place, an
epinephrine infusion was started at 0.01 mcg per kg
per min and titrated to 0.04 due to an acute drop in
blood pressure. Further vasoactive support with
vasopressin (started at 0.02 units per minute) was
required. Contrary to the norm, volume was
restricted during the case in light of the severe
cardiac status of the patient (660 mL of lactate
ringers and 500 mL of normal saline). Pain control
was attained by a post operative transverse
abdominis plane block using equal doses of 0.25%
Bupivacaine and liposomal Bupivacaine.
The patient tolerated surgical resection without
complication. Nitroglycerin was used to control
elevated blood pressure perioperatively, and this
was weaned off in the following 24 h. The patient's
anticoagulation regimen for his LVAD was resumed
on post-operative day 1, and he was transferred out
of the intensive care unit on post-operative day 2.
After surgery, he did develop volume overload
which was treated to intravenous furosemide before
transitioning the patient to his home regimen of
torsemide. Carvedilol was continued throughout the
perioperative period. The patient continued to do

good throughout hospital stay and was discharged
after 7 days. He was followed at 2 weeks interval and
3 months after discharge with no new issues or
complaints.

3. Discussion
We have described perioperative management of
a pheochromocytoma in a patient with a continuous
ﬂow LVAD. There are two common types of LVAD
as a mean of mechanical circulatory support, either
continuous ﬂow or pulsatile ﬂow. First generation
LVADs are pulsatile ﬂow pumps which are smaller
compared to the newer generation continuous ﬂow
LVADs. The later could be axial ﬂow or centrifugal
ﬂow pumps that are more reliable and provide durable support1.
Two cases have previously described pheochromocytoma
presenting
with
cardiomyopathy
requiring LVAD support.2,3 In prior descriptions,
the tumor was removed either during LVAD implantation or after LVAD explant.4,5
This case uniquely describes resection of the
tumor in a stable LVAD patient.
LVADs provide circulatory support that is essentially nonpulsatile. Continuous ﬂow results in
markedly increased sympathetic tone via a baroreceptor-mediated pathway. Pheochromocytoma
likewise alters sympathetic tone, and how this interacts with continuous circulatory ﬂow is not
known. Of note, the addition of pulsatile via pump
speed changes has been shown to reduce sympathetic nerve activity although not back to normal
physiologic levels.6 Current generation centrifugal
LVADs do incorporate an artiﬁcial “pulse” by transiently decreasing and increased LVAD speed 30
times per minute. The impact of this artiﬁcial pulse
on sympathetic tone is not known.

4. Conclusion
Traditional assessment of sympathetic tone is
challenging in LVAD patients due to the presence of
continuous circulatory ﬂow. Invasive management
via an arterial line was useful in perioperative
management, allowing for accurate circulatory
monitoring and hemodynamic control. Finally, close
coordination of multiple specialties including
advanced heart failure, anesthesia, and endocrinology was vital to the positive outcome in this case.
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